COFOE MEDICAL has announced that on August 31, 2026, it utilized 18.615 million yuan to repurchase 371,100 A-class shares.
The buyback reflects the company's ongoing capital management strategy, with the repurchased shares intended for future corporate purposes as previously outlined in its share repurchase program.
This transaction marks another step in the firm's efforts to enhance shareholder value through active market operations.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments